AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT00594828 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CoaguChek (Patient self testing)
Description: Patients will test their INR at home either biweekly, weekly or every 2 weeks using a CoaguChek point of care meter and communicate with the healthcare provider via an internet based expert system
Study NCT00594828 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Anticoagulation Management Service (AMS)
Description: Patients will attend the AMS for six months and have their INR checked every 4-6 weeks or more frequently, at the discretion of the clinician
Study NCT04264286 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Prophylactic esmolol
Description: Patients will receive prophylactic esmolol after the end of the surgery
Study NCT04264286 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Patients will prophylactic placebo after the end of the surgery
Study NCT03962335 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Vegetarian diet
Description: 7-days dietary profile with a Vegetarian diet (VD), containing inulin and resistant starch-rich foods and including no meat and fish, but containing eggs and dairy, for 3 months
Study NCT03962335 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Vegetarian diet
Description: 7-days dietary profile with a Vegetarian diet (VD), containing inulin and resistant starch-rich foods and including no meat and fish, but containing eggs and dairy, for 3 months
Study NCT03962335 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Mediterranean diet with butyrate
Description: 7-days dietary profile with Mediterranean diet with oral supplementation with butyrate (MD+Bt), 2 g/day, for 3 months
Study NCT03962335 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mediterranean diet with butyrate
Description: 7-days dietary profile with Mediterranean diet with oral supplementation with butyrate (MD+Bt), 2 g/day, for 3 months
Study NCT03962335 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Mediterranean diet
Description: 7-days dietary profile with Mediterranean diet (MD), including 2 portions per week of fish and 3 portions per week of fresh and processed meat (2 of which fresh or processed red meat), for 3 months
Study NCT03962335 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Description: 7-days dietary profile with Mediterranean diet (MD), including 2 portions per week of fish and 3 portions per week of fresh and processed meat (2 of which fresh or processed red meat), for 3 months
Study NCT03584672 — intervention group
Intervention type: OTHER
Intervention: Static Balance Test
Description: Balance control is assessed by the Static Balance Test.
Study NCT03584672 — intervention group
Intervention type: OTHER
Intervention: Berg Balance Scale
Description: Functional balance is assessed by the Berg Balance Scale.
Study NCT03584672 — intervention group
Intervention type: OTHER
Intervention: Timed Up an Go Test
Description: Functional mobility is assessed by the Timed Up and Go test.
Study NCT03584672 — intervention group
Intervention type: OTHER
Intervention: Four Square Step Test
Description: Dynamic balance is assessed by the Four Square Step Test.
Study NCT03584672 — intervention group
Intervention type: OTHER
Intervention: Functional Reach Test
Description: Limits of stability is assessed by the Functional Reach Test.
Study NCT03584672 — intervention group
Intervention type: OTHER
Intervention: One-leg Stance Test
Description: Postural steadiness is assessed by the One-leg Stance Test.
Study NCT02760134 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Super-Mini Percutaneous Nephrolithotomy
Description: Patients undergo Super-Mini Percutaneous Nephrolithotomy
Study NCT01529528 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anagliptin
Description: Anagliptin 100mg, tablet, BID
Study NCT01529528 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo of Anagliptin
Description: Placebo of Anagliptin 100mg, tablet, BID
Study NCT01917071 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: thoracic spine manipulation
Description: a manual technique applied to the mid back to promote motion
Study NCT01178229 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physiotherapy
Description: The physiotherapeutic intervention was based on the Awareness through Movement technique. Ten sessions were planed. Each session lasted three hours.~The children of the experimental group and their parents were guided by two physiotherapist and the sessions took place in a room rounded by mirrors.~Each session developed as follows: presentation to the parents of the somatic awareness technique for each day; movements, games, motor tales and exercises performed by the children; in each session, a guide book with cartoons was given to the children and their parents to reinforce the exercises at home to keep a long-term result.~All the children assisted together to all the sessions and the instructions and instruments given to the children and their parents were the same for all of them.
Study NCT01187082 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: bladdertraining in groups
Description: Cognitive training in groups of 4 patients at hospital by a continence nurse in 3 sessions (1 hour)over a period of 1 month. Follow up after 1 month. During all 2 month the patient has selfinitiatied daily training with a pocket bladder schedule.
Study NCT01187082 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: bladdertraining individually
Description: Cognitive training individually at hospital by a continence nurse in 3 sessions (1 hour)over a period of 1 month. Follow up after 1 month. During all 2 month the patient has selfinitiatied daily training with a pocket bladder schedule.
Study NCT05188352 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Chest physiotherapy
Description: The program included diaphragmatic breathing exercises, thoracic expansion exercises, incentive spirometer exercises, and coughing techniques.
Study NCT05188352 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Chest physiotherapy
Description: The program included diaphragmatic breathing exercises, thoracic expansion exercises, incentive spirometer exercises, and coughing techniques.
Study NCT05188352 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training
Description: A treadmill was used for aerobic exercise. Training intensity was used at 60-75% of maximal VO2.~Each session had a five-minute warm-up and cool-down period. Blood pressure and ECG were recorded during training sessions before exercise, at the third minute of each workload, after exercise, and during each minute of the recovery period.
Study NCT04655911 — intervention group
Intervention type: BIOLOGICAL
Intervention: ABO-101
Description: Gene therapy rAAV9.CMV.hNAGLU
Study NCT01715103 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: vaginal swabs by washing and cytobrush
Description: vaginal swabs by washing and cytobrush
Study NCT00219934 — intervention group
Intervention type: DRUG
Intervention: Antiretroviral therapy
Description: HAART therapy
Study NCT03040297 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Tracheal gas insufflation 6 L/min
Description: Endotracheal flow (6 L/min) of respiratory gases with standard FiO2
Study NCT03040297 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Tracheal gas insufflation 11 L/min
Description: Endotracheal flow (11 L/min) of respiratory gases with standard FiO2
Study NCT03040297 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Tracheal gas insufflation catheter, without gas flow
Description: Tracheal gas insufflation catheter, without gas flow
Study NCT04549948 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: 0.021X0.025 B-Titanium archwire
Description: Leveling curve of Sppe using 0.019X0.025 B-Titanium archwire
Study NCT04513041 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pinhole surgical technique and tunnel technique in a split mouth design
Description: Each subject will have the each surgical procedure which are both considered routine minimally invasive clinical care for gingival recession. Gum recession on one side will receive Pinhole surgical technique (test procedure). The other side will receive Tunnel technique (control procedure), Research component involved is the capture of digital impression using intra-oral scanner in the baseline (preoperative) and the final visit (6 months postoperative).
Study NCT02712359 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Blood sample collection
Description: A blood sample (\~5mL) will be collected from all subjects at each cross-sectional survey (Year 8 and Year 10).
Study NCT00577031 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: bevacizumab [Avastin]
Description: 7.5mg iv on day 1 of each 3 week cycle
Study NCT00577031 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxaliplatin
Description: 130mg/m2 iv on day 1 of each 3 week cycle
Study NCT00577031 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Xeloda
Description: 1000mg/m2 po bid on days 1-14 of each 3 week cycle
Study NCT04273659 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Pulses and cereals
Description: Dietary intervention. Ingestion of pulses with cereals and gastrointestinal health.
Study NCT02001038 — intervention group
Intervention type: OTHER
Intervention: Survey
Study NCT01204606 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Arthroscopic rotator cuff repair with intraoperative periarticular injection
Description: * Under general anesthesia, the patient was placed in the lazy lateral decubitus position on the operating table.~* The surgical area was prepared and draped with Betadine.~* Small stab incisions were made in the creation of 4 or 5 portals as needed.~* A scope was explored via the arthroscopic portal into the GH joint \& subacromial space.~* Repaired of rotator cuff tear was done with suture anchors.~* Mixed MMA drugs(ropivacaine 300mg;40ml, morphine 10mg;1ml, cefotetan 1g; dilution to ropivacaine, epinephrine 0.3mg;0.3ml, total volume:41.3ml) and sodium hyaluronate 20mg;2ml were injected divisionally periarticular area; intra-articular(sodium hyaluronate 20ml;2ml + 10.3ml); posterior joint capsule(10ml); subacromial space and around suprascapular nerve(11ml); anterior capsule(10ml).~* The skin was closed with Nylon or medical staples.~* Sterile dressing was applied on surgical wound.~* Peripheral intravenous PCA(Patient Controlled Analgesia) was connected.
Study NCT01204606 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Arthroscopic rotator cuff repair with non-injection of MMA drugs
Description: * Under general anesthesia, the patient was placed in the lazy lateral decubitus position on the operating table.~* The surgical area was prepared and draped with Betadine.~* Small stab incisions were made in the creation of 4 or 5 portals as needed.~* A scope was explored via the arthroscopic portal into the GH joint \& subacromial space.~* Repaired of rotator cuff tear was done with suture anchors.~* 43.3ml of saline was injected divisionally periarticular area; intra-articular(12.3ml); posterior joint capsule(10ml); subacromial space and around suprascapular nerve(11ml); anterior capsule(10ml).~* The skin was closed with Nylon or medical staples.~* Sterile dressing was applied on surgical wound.~* Peripheral intravenous PCA(Patient Controlled Analgesia) was connected.
Study NCT01439776 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vit D
Description: 800IU/day
Study NCT02751372 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BAY 987517
Description: 50 μl/cm\*2 or 0.05 gm/cm\*2 of each test product is applied to duplicate skin sites (approximately 2 x 2 cm each). After the test articles have dried for 5 to 15 min, the sites are covered by the appropriate patch.24 hours later, the set of patches covering the product are removed. Three (3) μl/ cm2 or 0.003 gm/cm\*2 of the test product is reapplied to the test site, air dried for 5 to 15 minutes for volatilization and then the test site is exposed to UVA radiation.
Study NCT02751372 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Untreated Skin
Description: This site is patched without treatment as irradiated control
Study NCT00733642 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: PF-04360365 1 mg/kg
Description: PF-04360365 1 mg/kg infused as a single dose
Study NCT03928483 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Modified WW Food program
Description: Participants will receive a structured, holistic, behavioral weight management program that encourages development of healthy habits to help individuals eat healthier, move more, and shift to a more helpful mindset.
Study NCT03376724 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Functional Exercise Protocol
Description: Functional exercise protocol. This protocol started with corporal conscience exercise, breathing, abdominal activation, activities such as sitting, getting up, climbing stairs, reaching with arms, moving forward, bodyweight exercises, bridges and boards. This protocol will be performed during 12 weeks, two sessions per week.
Study NCT03376724 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Minimal
Description: Analgesic use when necessary and a single back scholl class
Study NCT03376724 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Minimal
Description: Analgesic use when necessary and a single back scholl class
Study NCT01172691 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Inhaled Nitric Oxide (iNO)
Description: iNO or placebo will be administered at 40 ppm during the procedure starting when the Warm Ischemia Time begins - liver from ice. Stop when patient transported to ICU
Study NCT02837536 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Horizontal iCare
Description: IOP of the right eye will be measured using the iCare tonometer held in the horizontal position first and then in the vertical position.
Study NCT02837536 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Vertical iCare
Description: IOP of the right eye will be measured using the iCare tonometer held in the vertical position first and then in the horizontal position.
Study NCT00850200 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Proton Radiation Plan
Description: Between 21-39.6 Gy/CGE to the PTV
Study NCT00850200 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Photon Radiation Plan
Description: Between 21-39.6 Gy/CGE to the PTV
Study NCT00850200 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Intensity Modulated Radiation Plan
Description: Between 21-39.6 Gy/CGE to the PTV
Study NCT00733642 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: PF-04360365 3 mg/kg
Description: PF-04360365 3 mg/kg infused as a single dose
Study NCT00733642 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: PF-04360365 5 mg/kg
Description: PF-04360365 5 mg/kg infused as a single dose
Study NCT00733642 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: PF-04360365 10 mg/kg
Description: PF-04360365 10 mg/kg infused as a single dose
Study NCT03597126 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Robot-assisted surgery
Description: robot-assisted intersphincteric resection for low location rectal cancer(T=1\&2)
Study NCT02234908 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Contacts
Description: Household contacts who come to the study clinic, present a referral card, and complete TB symptom screening will receive a shopping voucher of $5-10 value.
Study NCT02234908 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Index
Description: Index subjects will be entered in a prize lottery if any of their contacts complete TB symptom screening at the study clinic.
Study NCT00333112 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: solifenacin succinate
Description: Oral
Study NCT00333112 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: tamsulosin
Description: oral
Study NCT00333112 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: tamsulosin
Description: oral
Study NCT03597126 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Laparoscopic surgery
Description: laparoscopic intersphincteric resection for low location rectal cancer(T=1\&2)
Study NCT00666328 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: clevidipine
Description: Clevidipine injectable emulsion (0.5 mg/mL) in 20% lipid emulsion in 100 mL bottles was administered intravenously to all patients via a single dedicated line.~Clevidipine was infused at an initial rate of 2.0 mg/h for the first 1.5 minutes. Thereafter, titration to higher infusion rates were to be attempted as needed to obtain the target systolic blood pressure (SBP) range (SBP ≤160 mmHg to ≥140 mmHg). Titration to effect was to proceed by doubling the dose every 1.5 minutes, up to a maximum of 32.0 mg/h, until the desired effect (SBP within the target range) was attained. The clevidipine infusion rate could be increased or decreased to maintain systolic blood pressure for up to a maximum of 96 hours.
Study NCT00333112 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: oral
Study NCT04430959 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Candesartan
Description: Candesartan 4 mg, tablets, orally, once daily for 4 weeks
Study NCT04430959 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Candesartan
Description: Candesartan 4 mg, tablets, orally, once daily for 4 weeks
Study NCT04430959 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Candesartan placebo-matching tablets, orally, once daily for 4 weeks
Study NCT02621528 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: CeraFlex
Description: The Lifetech CeraFlex™ study is a triple-arm study.
Study NCT01277172 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Rituximab
Description: 375 mg/m2 IV every 2 weeks for 6 cycles
Study NCT01420302 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Nurse directed
Description: Nurse directed insulin titration to establish glycemic control in the target range of 80-110 mg/dL
Study NCT01420302 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: LOGIC-Insulin
Description: Blood glucose control (80-110 mg/dL) guided by the LOGIC-Insulin algorithm
Study NCT02711800 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus
Description: The investigators will use Culturelle®, a probiotic composed of the micro-organisms Lactobacillus GG. This formulation has been used for the treatment of gastrointestinal inflammation in numerous clinical trials. Dosing will follow the manufacturer's recommendation for children (1 capsule/packet per day), and will be monitored by the study Co-PI, Dr. Seed. Weekly side effects and clinical changes will be monitored by both study therapist and caregiver using the Children's Global Assessment Scale and the Clinical Global Impression Scale (Severity, Improvement, and Efficacy). The treatment duration is 30 days.
Study NCT00839839 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Oocyte Vitrification
Description: All oocytes retrieved will be vitrified (rapidly frozen) after egg retrieval. The oocytes will then be warmed on the same day and fertilized per standard IVF-ICSI. Resulting embryos will be transferred back to the patient as per protocol.
Study NCT00003255 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: carboplatin
Study NCT00003255 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: topotecan hydrochloride
Study NCT03611725 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Distal radial artery
Description: The distal radial artery will be punctured with a puncture needle. Then, coronary angiography and percutaneous coronary intervention will be performed.
Study NCT03611725 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Radial artery
Description: The radial artery will be punctured with a puncture needle. Then, coronary angiography and percutaneous coronary intervention will be performed.
Study NCT04805307 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CMG901
Description: CMG901 will be administered intravenously (IV) on Day 1 of every 21-day cycle. Individual subjects may continue study treatment until there is evidence of disease progression (clinical or radiologic) judged by Investigators, unacceptable toxicity or other reasons for treatment discontinuation.
Study NCT04430959 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Candesartan placebo-matching tablets, orally, once daily for 4 weeks
Study NCT01277172 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Rituximab
Description: 375 mg/m2 IV every 2 weeks for 6 cycles
Study NCT02565745 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Skin dressing
Description: Pre-determined skin areas at risk for PUs (3 or more, depending on the prevaliing body position, prone, supine or Sims') will be covered. Dressings will be changed every 6-7 days unless found wet/contaminated
Study NCT01277172 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Rituximab
Description: 375 mg/m2 IV every 14 days for 6 cycles